The programme features headline data from pivotal Phase III trials, including PREVAIL in gMG, KOMET in NF1-PN, and CHAMPION-NMOSD, alongside real-world evidence supporting established therapies
A major push to sharpen the future of cancer treatment is underway
The study’s multi-technology design is intended to improve reproducibility, strengthen regulatory-grade evidence generation
Policy, regulations, AI and CRDMO take centre stage at the flagship event of the Department of Pharmaceuticals
Veteran biopharma leader stressed that generic medicines must be viewed separately from biologics
The FDA is also reviewing the application under its Real-Time Oncology Review (RTOR) program and Project Orbis
Benefits were consistent across all key subgroups, including patients previously treated with covalent BTK inhibitors
The conference focuses on the latest advances in cancer diagnosis, treatment, and patient-centric care
The two-day conference and exhibition features discussions on policy frameworks, AI-led drug discovery, next-generation technologies, and global competitiveness
Green Vision Centres cut emissions, expand community coverage as partners align on resilient eye health systems
Subscribe To Our Newsletter & Stay Updated
